ATE438647T1 - N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid - Google Patents
N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochloridInfo
- Publication number
- ATE438647T1 ATE438647T1 AT08008434T AT08008434T ATE438647T1 AT E438647 T1 ATE438647 T1 AT E438647T1 AT 08008434 T AT08008434 T AT 08008434T AT 08008434 T AT08008434 T AT 08008434T AT E438647 T1 ATE438647 T1 AT E438647T1
- Authority
- AT
- Austria
- Prior art keywords
- dimethylamino
- oxo
- propenylüphenylü
- hyl
- acetamide hydrochloride
- Prior art date
Links
- FZSDJRKAWHMQFF-UHFFFAOYSA-N n-[3-[3-(dimethylamino)prop-2-enoyl]phenyl]-n-ethylacetamide;hydrochloride Chemical compound Cl.CCN(C(C)=O)C1=CC=CC(C(=O)C=CN(C)C)=C1 FZSDJRKAWHMQFF-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Anesthesiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0400325A HUP0400325A3 (en) | 2004-02-02 | 2004-02-02 | Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE438647T1 true ATE438647T1 (de) | 2009-08-15 |
Family
ID=89981959
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708499T ATE420882T1 (de) | 2004-02-02 | 2005-01-31 | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid |
| AT08008434T ATE438647T1 (de) | 2004-02-02 | 2005-01-31 | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05708499T ATE420882T1 (de) | 2004-02-02 | 2005-01-31 | Verfahren zur synthese von n-ä3-(3- cyanopyrazoloä1,5aüpyrimidin-7-yl)-phenylü-n- ethylacetamid |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP1950213B1 (de) |
| JP (1) | JP2007519700A (de) |
| AT (2) | ATE420882T1 (de) |
| DE (2) | DE602005012365D1 (de) |
| EA (1) | EA010830B1 (de) |
| HU (1) | HUP0400325A3 (de) |
| NO (1) | NO20063917L (de) |
| RS (1) | RS20060427A (de) |
| WO (1) | WO2005073235A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099712A2 (en) * | 2004-04-19 | 2005-10-27 | Sanmar Speciality Chemicals Limited | Process for preparation of n-[3-(3-cyanopyrazolo [1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| WO2006070244A2 (en) * | 2004-11-22 | 2006-07-06 | Bakulesh Mafatlal Khamar | A process for the preparation of zaleplon |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626538A (en) | 1983-06-23 | 1986-12-02 | American Cyanamid Company | [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines |
| US5714607A (en) * | 1995-12-01 | 1998-02-03 | American Cyanamid Company | Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| WO2002100828A2 (en) * | 2001-06-12 | 2002-12-19 | Biogal Gyogyszergyar Rt | Process for the production of zaleplon |
| US6852858B2 (en) * | 2001-08-01 | 2005-02-08 | Biogal Gyogyszergyar Rt. | Process for purifying N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-N-ethylacetamide (zaleplon) and crystalline forms of zaleplon accessible with the process |
| PL207322B1 (pl) * | 2002-05-14 | 2010-11-30 | Adamed Społka Z Ograniczoną Odpowiedzialnością | Sposób wytwarzania zaleplonu |
-
2004
- 2004-02-02 HU HU0400325A patent/HUP0400325A3/hu unknown
-
2005
- 2005-01-31 AT AT05708499T patent/ATE420882T1/de not_active IP Right Cessation
- 2005-01-31 EP EP08008434A patent/EP1950213B1/de active Active
- 2005-01-31 RS RSP-2006/0427A patent/RS20060427A/sr unknown
- 2005-01-31 JP JP2006550312A patent/JP2007519700A/ja active Pending
- 2005-01-31 DE DE602005012365T patent/DE602005012365D1/de not_active Expired - Fee Related
- 2005-01-31 EA EA200601417A patent/EA010830B1/ru not_active IP Right Cessation
- 2005-01-31 EP EP05708499A patent/EP1711501B1/de active Active
- 2005-01-31 AT AT08008434T patent/ATE438647T1/de not_active IP Right Cessation
- 2005-01-31 WO PCT/HU2005/000008 patent/WO2005073235A2/en active Application Filing
- 2005-01-31 DE DE602005015902T patent/DE602005015902D1/de not_active Expired - Fee Related
-
2006
- 2006-09-01 NO NO20063917A patent/NO20063917L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HU0400325D0 (en) | 2004-04-28 |
| EP1950213A3 (de) | 2008-08-13 |
| EP1711501A2 (de) | 2006-10-18 |
| WO2005073235A2 (en) | 2005-08-11 |
| EA010830B1 (ru) | 2008-12-30 |
| HUP0400325A2 (hu) | 2005-09-28 |
| EP1950213B1 (de) | 2009-08-05 |
| EP1950213A2 (de) | 2008-07-30 |
| JP2007519700A (ja) | 2007-07-19 |
| EA200601417A1 (ru) | 2006-12-29 |
| DE602005012365D1 (de) | 2009-03-05 |
| ATE420882T1 (de) | 2009-01-15 |
| DE602005015902D1 (de) | 2009-09-17 |
| HUP0400325A3 (en) | 2005-11-28 |
| EP1711501B1 (de) | 2009-01-14 |
| NO20063917L (no) | 2006-11-01 |
| WO2005073235A3 (en) | 2005-10-06 |
| RS20060427A (en) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1109599T1 (el) | Κρυσταλλικες μορφες υδροχλωρικης (r)-8-χλωρο-1-μεθυλο-2,3,4,5-τετραϋδρο-1η-3-βενζαζεπινης | |
| ATE368639T1 (de) | Kristalline formen von (-)-(1r,2r)-3-(3- dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochlorid | |
| EP1740559A4 (de) | Als ?-sekretase-inhibitoren für die behandlung von alzheimer-krankheit geeignete 1,3,5-substituierte phenylderivatverbindungen | |
| MY141255A (en) | Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs | |
| ZA200804498B (en) | N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ERBB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| HK1110588A1 (en) | Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
| NO20062644L (no) | DPP-IV inhibitorer | |
| MX2007004637A (es) | Sintesis asimetrica de derivados de dihidrobenzofurano. | |
| BR0213931A (pt) | Forma polimórfica de rimonabant, processo para sua preparação e composições farmacêuticas contendo-as | |
| ATE452882T1 (de) | Herstellung von quetiapin | |
| HK1078315A1 (en) | Synthesis of 2-hydroxy-n,n-dimethyl-3- 2- 1(r)-(5-methyl-2-furanyl)propyl amino -3,4-dioxo-1-cyclobuten- 1-yl amino benzamide | |
| IN2012DN00758A (de) | ||
| NO20070550L (no) | Fremgangsmate for fremstilling av pyrrolotriazinforbindelser | |
| IL155041A0 (en) | Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds | |
| ATE438647T1 (de) | N-ä3- ä3-(dimethylamino)-1-oxo-2-propenylüphenylü-n-e hyl-acetamide hydrochlorid | |
| NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| WO2008072079A3 (en) | Processes for the preparation of 3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2h)-yl)-n,4-dimethylbenzamide | |
| DE602007012725D1 (de) | Verfahren zur Herstellung von N-(Diphenylmethyl)piperazinen | |
| PT1501516E (pt) | Processo para a preparacao de cloridrato de benazepril | |
| TW200603801A (en) | Novel dialkoxy-imidazopyridines | |
| ATE340161T1 (de) | Herstellung von quinapril hydrochlorid | |
| TW200613301A (en) | Novel amino-halogen-imidazopyridines | |
| PL377984A1 (pl) | Sposób wytwarzania N-(5-amino-2-metylofenylo)-4-(3-pirydylo)-2-pirymidynoaminy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |